Items where authors include "Rathbone, E"

Export as [feed] Atom [feed] RSS
Number of items: 6.

Article

Winter, M, Coleman, R, Kendall, J orcid.org/0000-0003-2884-4849 et al. (13 more authors) (2022) A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results. Journal of Bone Oncology, 35. 100442. ISSN 2212-1374

Coleman, R, Brown, J, Rathbone, E et al. (9 more authors) (2020) CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial. Trials, 21. 89. ISSN 1745-6215

Brown, J, Rathbone, E, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. Journal of the National Cancer Institute, 110 (8). pp. 871-879. ISSN 0027-8874

Coleman, R, Cameron, D, Dodwell, D et al. (13 more authors) (2014) Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. The Lancet Oncology, 15 (9). 997 - 1006. ISSN 1470-2045

Conference or Workshop Item

Grassi, A orcid.org/0000-0002-7656-0480 and Rathbone, E (2023) “Can you believe that?” – On fashion brands green communications and gen z’s perception of brand credibility. In: 2023 Global Marketing Conference at Seoul, 20-23 Jul 2023, Seoul, Republic of Korea. (Unpublished)

Winter, M, Kendall, J, Brown, S orcid.org/0000-0002-7975-7537 et al. (9 more authors) (2021) PS14-02: A randomised phase IB/IIA study of CApecitabine plus Radium-223 in breast cancer patients with BONe metastases (CARBON) - Safety and preliminary efficacy findings. In: 2020 San Antonio Breast Cancer Virtual Symposium, 08-11 Dec 2020, San Antonio, Texas, USA.

This list was generated on Sun Mar 24 14:38:21 2024 GMT.